Botulinum neurotoxins, the causative agents of the potentially fatal disease of botulism, are produced by certain Clostridium strains during vegetative growth, usually in anaerobic environments. Our findings indicate that, contrary to current understanding, the growth of neurotoxigenic C. butyricum strains and botulinum neurotoxin type E production can continue upon transfer from anaerobic to aerated conditions and that adaptation of strains to oxygenated environments requires global changes in proteomic and metabolic profiles. We hypothesize that aerotolerance might constitute an unappreciated factor conferring physiological advantages on some botulinum toxin-producing clostridial strains, allowing them to adapt to otherwise restrictive environments.
KEYWORDS: Clostridium butyricum, botulinum neurotoxin, oxidative stress
ABSTRACT
Clostridium butyricum, the type species of the genus Clostridium, is considered an obligate anaerobe, yet it has been shown to grow in the presence of oxygen. C. butyricum strains atypically producing the botulinum neurotoxin type E are the leading cause of type E human botulism in Italy. Here, we show that type E botulinum neurotoxin-producing C. butyricum strains growing exponentially were able to keep growing and producing toxin in vitro upon exposure to air, although less efficiently than under ideal oxygen-depleted conditions. Bacterial growth in air was maintained when the initial cell density was higher than 103 cells/ml. No spores were detected in the cultures aerated for 5 h. To understand the biological mechanisms allowing the adaptation of vegetative cells of C. butyricum type E to oxygen, we compared the proteome and metabolome profiles of the clostridial cultures grown for 5 h under either aerated or anaerobic conditions. The results indicated that bacterial cells responded to oxygen stress by slowing growth and modulating the expression of proteins involved in carbohydrate uptake and metabolism, redox homeostasis, DNA damage response, and bacterial motility. Moreover, the ratio of acetate to butyrate was significantly higher under aeration. This study demonstrates for the first time that a botulinum neurotoxin-producing Clostridium can withstand oxygen during vegetative growth.
IMPORTANCE Botulinum neurotoxins, the causative agents of the potentially fatal disease of botulism, are produced by certain Clostridium strains during vegetative growth, usually in anaerobic environments. Our findings indicate that, contrary to current understanding, the growth of neurotoxigenic C. butyricum strains and botulinum neurotoxin type E production can continue upon transfer from anaerobic to aerated conditions and that adaptation of strains to oxygenated environments requires global changes in proteomic and metabolic profiles. We hypothesize that aerotolerance might constitute an unappreciated factor conferring physiological advantages on some botulinum toxin-producing clostridial strains, allowing them to adapt to otherwise restrictive environments.
INTRODUCTION
Bacteria of the genus Clostridium are conventionally defined as obligate anaerobes, i.e., they have an oxygen-independent metabolism and could be killed by exposure to oxygen or form resistant spores that germinate into vegetative cells when the conditions become favorable. During vegetative growth, the toxigenic clostridial species produce toxins. Therefore, although clostridial spores are commonly isolated from environments and food products in normal atmospheric oxygen tensions, spore germination and vegetative growth—and toxin production by toxigenic species—occur only in the absence of oxygen (1).
However, while the germination of clostridial spores is rare in the presence of low oxygen concentrations, evidence suggests that vegetative cells may display considerable ability to tolerate oxygen (2, 3).
Based on current approaches, different levels of oxygen tolerance during the vegetative stage have been reported in strains of Clostridium butyricum (2, 4), which is the type species of the genus, as well as in other nontoxigenic Clostridium species, including C. acetobutylicum, C. aminovalericum, C. bifermentans, C. puniceum, C. ljungdahlii, C. tertium, and C. glycolicum (5–12), and—of critical importance to human health—in toxigenic species such as C. difficile and C. perfringens (13–15).
Oxygen tolerance among clostridia has been attributed to the enzymatic ability of strains to consume oxygen from the medium and to defend themselves against the toxic effects of the reactive oxygen species (ROS) (2, 4, 16). Recently, a strategy based on the synthesis of aromatic polyketides (clostrubins) has been proposed for the plant pathogen C. puniceum to survive and grow in aerated environments; nonetheless, the antioxidant role of clostrubins has not been determined (9).
Certain clostridial strains produce the botulinum neurotoxin (BoNT): this protein toxin usually causes severe paralysis in humans when it is synthesized by BoNT-producing clostridia in the colonized intestine, especially in infants younger than 1 year (infant botulism); in infected wounds (wound botulism); or in contaminated food products before consumption (foodborne botulism) (17). Oxygen may not be completely absent from these environments. The newborn intestine is known to be aerobic until it is made anaerobic by oxygen-reducing aerobes (18), wounds come in contact with ambient air, and even the contaminated food products at risk of botulism may be subject to air infiltration. Therefore, studying the responses of BoNT-producing clostridia to oxygen exposure, especially in the vegetative growth phase when they produce BoNT, is imperative for better understanding the within-host dynamics and implementing food safety control measures.
Type E BoNT (BoNT/E), i.e., one of the antigenically different BoNT types causing human botulism, is usually synthesized by C. botulinum type E strains but can also be produced by atypical neurotoxigenic C. butyricum type E strains (17). In Italy, where neurotoxigenic C. butyricum type E strains were first isolated from infants with botulism and then repeatedly recovered from cases of human botulism, these strains appear to be clinically more relevant than C. botulinum type E strains (19). Moreover, neurotoxigenic C. butyricum type E strains have been associated with human botulism in Asia, the United Kingdom, and the United States, contributing to the reemergence of this microorganism as a causative agent of botulism (20–23).
Although it has been reported that nonneurotoxigenic C. butyricum strains grow in oxygen-containing environments, little is known about the behavior of neurotoxigenic C. butyricum type E strains upon oxygen exposure. The present study aimed to investigate the effects of atmospheric oxygen exposure on the vegetative growth of neurotoxigenic C. butyricum type E strains and BoNT/E production and characterize the strategic defense mechanisms adopted by these microorganisms upon air exposure.
RESULTS
Effects of air exposure on the vegetative growth of neurotoxigenic C. butyricum type E strains and BoNT/E production.
The broth cultures of the C. butyricum type E strains ISS-21 and ISS-190 in the mid-exponential-growth phase were analyzed in parallel during a 5-h incubation either under anaerobic (AN) conditions or following ambient air exposure (aerated [AE] conditions).
At the end of the experiments, the average concentrations of dissolved oxygen in AE cultures were 5.2 ± 1 ppm, whereas oxygen was not detectable in AN cultures. The average pH was 5.35 ± 0.15 in both AN and AE cultures.
The two strains exhibited similar OD600 growth curves under AN and AE conditions over the 5-h culture period, with an overall ∼2-fold increase in the OD600 values and no significant differences between each tested time point (Fig. 1A and B). As the OD600 values measure the turbidity of bacterial suspensions regardless of cell viability, the viable cells in the starting (mid-exponential-growth-phase) cultures and final cultures in AN and AE environments were counted. The average cell count of strains ISS-190 and ISS-21 in the starting cultures was ∼103 and 104 cells/ml, respectively (Fig. 1A and B). After 5 h of incubation under AN conditions, the average viable cell count in strains ISS-190 and ISS-21 was 9.4 × 105 cells/ml and 1.5 × 107 cells/ml, respectively; in contrast, the average viable cell count in strains ISS-190 and ISS-21 after a 5-h incubation under AE conditions was 6.5 × 104 and 1.2 × 106 cells/ml, respectively. Therefore, the number of viable cells at the end of the experiments was higher in AN cultures than in AE cultures, and the difference in the average viable cell count under AN and AE conditions was significant only for strain ISS-21 (P < 0.05) (Fig. 1A and B). In addition, the average cell count at the end of the experiments was significantly higher in strain ISS-21 than in strain ISS-190 in the AN environment, whereas there was no statistically significant difference between the strains in the AE environment.
Of note is that, at the end of the growth period, gas bubbles were visible in strains cultivated under AN conditions but were not visible in strains grown under AE conditions (Fig. 1C). Importantly, no spores were detected by staining or heat shock in both neurotoxigenic C. butyricum type E strains in the AE environment (data not shown).
Since it is known that bacteria respond to changes in environmental conditions in a cell-density-dependent manner (24), we determined the minimum initial bacterial density necessary to promote growth under AE conditions. The results indicated that both C. butyricum type E strains could grow under AE conditions when the initial density was at least 103 cells/ml of bacteria growing exponentially (Fig. 1D).
With regard to BoNT/E production, BoNT/E protein and toxicity levels were measured in the starting cultures of both strains and in the cultures maintained in the AN environment for 24 h (when the BoNT/E levels should be highest) (25) or incubated in the AE environment for the same time. As expected, BoNT/E protein levels determined by an immuno-ELISA were low in the starting cultures, with no significant differences between the two strains (Fig. 2). The production of BoNT/E protein was increased approximately 58-fold and 36-fold in strains ISS-21 and ISS-190, respectively, after culturing under AN conditions for 24 h and approximately 25-fold and 20-fold in the same strains under AE conditions for 24 h. Therefore, the increase in BoNT/E protein levels in the AE environment was significantly lower than in the AN environment for both strains (P < 0.05). Furthermore, while the BoNT/E protein levels were significantly higher in strain ISS-21 than in strain ISS-190 under AN conditions for 24 h (P < 0.05), the BoNT/E protein levels were similar between the two strains under AE conditions for 24 h (Fig. 2). The BoNT/E toxicity levels measured using a mouse bioassay were increased 32-fold and 8-fold in strains ISS-21 and ISS-190 cultured under AN conditions for 24 h, respectively, and 4-fold and 2-fold in the same strains under AE conditions for 24 h, respectively (Fig. 2). The increase in BoNT/E protein and toxicity levels was more evident in strain ISS-21 than in strain ISS-190, especially in the AN environment, and this result is consistent with the significantly higher growth rate of the former strain under these culture conditions.
Effects of air exposure on protein expression.
As C. butyricum type E strain ISS-190 appeared less affected by air exposure than strain ISS-21, considering the more similar growth characteristics and BoNT/E production under AE and AN conditions, strain ISS-190 was selected for the comparative proteomics analysis. The C. butyricum type E strains ISS-190 and ISS-21 are clonally related, with most of the genetic diversity between the strains consisting of an ∼168-kb genetic region that is present in the ISS-190 genome but missing from the ISS-21 genome (26).
To identify differentially expressed proteins (DEPs) following air exposure, proteins from cells grown under AN or AE conditions were analyzed by proteomic analysis. A total of 953 proteins were detected; however, only 598 proteins were consistently identified in at least 3 of 5 replicates and were therefore selected for further analyses (see Table S1 in the supplemental material). Among them, 8 and 11 proteins were uniquely expressed in either the AE or AN environment, whereas 579 were identified in both environments and were subjected to quantitative analysis. Of these, 76 proteins were upregulated and 24 were downregulated under AE conditions compared to AN conditions (Fig. 3). The analysis of proteins modulated by air exposure indicated that protein-protein interactions were enriched (P value of 6.3e−10), suggesting that specific protein complexes and/or networks were likely affected by oxygen (Fig. S1).
The DEPs were categorized by function (Table 1 and Fig. 4). The results indicate that the modulation of biological processes depends on the AE/AN growth conditions (Fig. 5). The most affected biological processes were membrane transport, redox homeostasis, carbohydrate metabolism, sulfur metabolism, and protein translation. The expression of ribosomal proteins was decreased under AE conditions. On the other hand, proteins involved in cell redox homeostasis, antioxidant defense, and sulfur metabolism and some proteins involved in the transport of solutes across membranes, particularly sugars and proteins, were overexpressed after air exposure. Similarly, several proteins involved in DNA damage responses and flagellum-associated proteins were more abundant under AE conditions.
TABLE 1.
Protein expression type, category, and no. |
NCBI accession no. |
Gene name | Protein name | FCa | Notesb | Biological process |
---|---|---|---|---|---|---|
Upexpressed | ||||||
Biological process not assigned |
||||||
1 | 489509402 | CLP_2689 | Phage major tail protein | 1.89 | Biol GO not assigned | |
2 | 489502155 | CLP_3314 | Metallophosphoesterase | 0.69 | Biol GO not assigned | |
3 | 488646122 | CLP_3861 | Outer surface protein | * | Biol GO not assigned | |
4 | 489502201 | CLP_3345 | Uncharacterized protein | 1.55 | Biol GO not assigned | |
5 | 489504250 | CLP_1280 | Uncharacterized protein | 1.16 | Biol GO not assigned | |
6 | 489504278 | CLP_1290 | Uncharacterized protein | 1.28 | Biol GO not assigned | |
7 | 489504289 | CLP_1282 | Uncharacterized protein | * | Biol GO not assigned | |
8 | 489504297 | CLP_1288 | Uncharacterized protein | 1.31 | Biol GO not assigned | |
9 | 489504751 | CLP_2775 | Putative lipoprotein | 2.24 | Biol GO not assigned | |
10 | 489503695 | CLP_3097 | Putative lipoprotein | 0.70 | Biol GO not assigned | |
11 | 489509462 | CLP_1648 | Major capsid protein | * | Biol GO not assigned | |
12 | 489504253 | CLP_1279 | Uncharacterized protein | 1.54 | Biol GO not assigned: likely phage |
|
13 | 489504296 | CLP_1287 | Baseplate J family protein | 1.29 | Biol GO not assigned: likely phage |
|
14 | 237656561 | CLP_1654 | Uncharacterized protein | * | Biol GO not assigned: likely PTS |
|
Carbohydrate metabolism |
||||||
15 | 488642402 | CLP_0032 | N-Acetylneuraminate lyase (NanA) | 2.89 | Carbohydrate metabolism: sialic acid catabolism |
|
16 | 489505355 | CLP_0171 |
N-Acetylmannosamine-6- phosphate 2-epimerase (NanE) |
4.50 | Carbohydrate metabolism: sialic acid catabolism |
|
17 | 489503203 | CLP_0041 | Beta-glucosidase | * | Glycoside hydrolase | Carbohydrate metabolism |
18 | 489502642 | CLP_0871 | Alpha,alpha-phosphotrehalase | 1.32 | Glycoside hydrolase | Carbohydrate metabolism |
19 | 489505662 | CLP_1017 | Alpha amylase, catalytic region | 1.64 | Glycoside hydrolase | Carbohydrate metabolism |
20 | 489502184 | CLP_3347 | Glycosyl hydrolase family 32, N domain protein |
3.15 | Glycoside hydrolase | Carbohydrate metabolism |
21 | 488644093 | CLP_1327 | Hydroxyacylglutathione hydrolase | 1.57 | Carbohydrate metabolism | |
22 | 488646082 | CLP_3906 | Ribose-5-phosphate isomerase B | 3.45 | Carbohydrate metabolism | |
23 | 489502147 | CLP_3305 | dTDP-4-dehydrorhamnose 3,5-epimerase |
1.35 | Carbohydrate metabolism | |
24 | 489503814 | CLP_3464 | UDP-N-acetylglucosamine 4,6-dehydratase |
* | Carbohydrate metabolism | |
25 | 489507281 | CLP_4271 | Aldose 1-epimerase | 0.65 | Carbohydrate metabolism | |
Peptidoglycan metabolism |
||||||
26 | 489504484 | CLP_3010 | Penicillin-binding protein | 2.12 | Peptidoglycan metabolism | |
27 | 489502929 | CLP_0014 | Cell wall hydrolase/autolysin | 4.04 | Peptidoglycan metabolism | |
Redox homeostasis | ||||||
28 | 488644028 | CLP_1392 | FAD-dependent oxidoreductase | 0.94 | Fe-S | Redox homeostasis |
29 | 488644495 | CLP_1011 | ArsC family protein | 2.63 | Redox homeostasis | |
30 | 488644556 | CLP_0948 | Redoxin | 1.37 | Redox homeostasis | |
31 | 489501807 | CLP_2414 | NADH oxidase | 2.89 | NADH→NAD | Redox homeostasis |
32 | 489503213 | CLP_0082 | Oxidoreductase NAD-binding domain protein |
2.16 | NAD→NADH | Redox homeostasis |
33 | 489505820 | CLP_3877 | FAD-linked oxidase domain protein |
1.58 | FAD→FADH | Redox homeostasis |
34 | 489506590 | CLP_0595 | Thioredoxin-disulfide reductase | 3.25 | FAD→FADH, NAD→NADH |
Redox homeostasis |
35 | 489506753 | CLP_0519 | MviM protein NAD(P)-dependent oxidoreductase |
3.25 | NADP→NADPH | Redox homeostasis |
36 | 489507464 | CLP_4064 | Thioredoxin reductase | 1.74 | NADP→NADPH | Redox homeostasis |
37 | 489510856 | CLP_0102 | Rubrerythrin | 1.45 | Fe | Redox homeostasis |
38 | 488644026 | CLP_1394 | Zinc finger protein | 0.67 | Redox homeostasis | |
39 | 489502510 | CLP_2859 | Ribosome-binding ATPase YchF | 3.21 | Redox homeostasis | |
Sulfur metabolism | ||||||
40 | 489504716 | CLP_1763 | Cystathionine beta-lyase, MetC | 2.10 | Sulfur metabolism: amino acid metabolism |
|
41 | 489507701 | CLP_3701 |
S-Adenosylmethionine synthase, MetK |
1.02 | Sulfur metabolism: Cys and Met metabolism |
|
42 | 489505568 | CLP_1012 | Sulfite reductase | 1.25 | Fe-S | Sulfur metabolism: H2S biosynthesis—redox homeostasis |
43 | 237656426 | CLP_2257 | Sulfate adenylyltransferase subunit 1-bifunctional enzyme CysN/CysC |
2.93 | Sulfur metabolism: H2S biosynthesis—sulfate reduction |
|
44 | 489501666 | CLP_2258 | Sulfate adenylyltransferase subunit 2-bifunctional enzyme CysN/CysC |
* | Sulfur metabolism: H2S biosynthesis—sulfate reduction |
|
45 | 488642894 | CLP_2741 | Cysteine desulfurase IscS | 1.18 | Fe-S | Sulfur metabolism: (Fe-S) cluster biosynthesis |
Transport | ||||||
Protein transport |
||||||
46 | 488644099 | CLP_1321 | Protein translocase subunit SecD | 1.20 | P-P hydrolase | Protein transport |
47 | 489510437 | CLP_1322 | Protein-export membrane protein SecF |
0.64 | P-P hydrolase | Protein transport |
48 | 489504061 | CLP_3432 | Chemotaxis protein MotA | 0.69 | Protein transport | |
Sugar transport | ||||||
49 | 488646019 | CLP_3984 | Phosphoenolpyruvate-protein phosphotransferase |
1.19 | Sugar PTS | Sugar transport |
50 | 489503218 | CLP_0055 | PTS, lactose/cellobiose family IIB component |
2.05 | Sugar PTS | Sugar transport |
51 | 489505845 | CLP_3908 | PTS enzyme IIC component, galactitol transporter |
2.57 | Sugar PTS | Sugar transport |
52 | 489505963 | CLP_3910 | PTS enzyme IIBC component, fructose transporter |
2.96 | Sugar PTS | Sugar transport |
53 | 489507776 | CLP_3760 | Lichenan-specific phosphotransferase enzyme IIA component, cellobiose transporter |
3.21 | Sugar PTS | Sugar transport |
54 | 489508885 | CLP_3296 | CspC, N-acetylmuramoyl- l-alanine amidase family protein |
0.88 | Hydrolase | Sugar transport: peptidoglycan amidohydrolase |
55 | 489501903 | CLP_2323 | Putative sugar-binding secreted protein |
4.50 | ABC transporter | Sugar transport: peptidoglycan amidohydrolase |
Transmembrane transport |
||||||
56 | 489510211 | CLP_2264 | Sulfate transporter subunit, sulfate starvation-induced protein 2 |
1.86 | ABC transporter | Transmembrane transport |
57 | 489507313 | CLP_4206 | ABC transporter, ATP-binding protein | 2.04 | ABC transporter | Transmembrane transport |
58 | 489502974 | CLP_2166 | Amino acid permease- associated region |
3.44 | Transmembrane transport | |
59 | 489504117 | CLP_2003 | Efflux transporter, RND family | 3.09 | Transmembrane transport | |
60 | 488644700 | CLP_0371 | Extracellular solute-binding protein family 3 |
0.91 | Transmembrane transport | |
61 | 489506027 | CLP_3956 | Extracellular solute-binding protein, family 1 |
0.77 | Transmembrane transport | |
62 | 489502966 | CLP_2159 | Spermidine/putrescine import ATP-binding protein PotA |
0.86 | Transmembrane transport | |
Membrane protein |
||||||
63 | 489505750 | CLP_1031 | ErfK/YbiS/YcfS/YnhG family protein |
1.22 | Membrane protein | |
64 | 488645963 | CLP_4057 | PilT protein domain protein | 1.47 | Membrane protein | |
65 | 489502814 | CLP_1221 | V-type ATP synthase subunit D | 3.67 | Plasma membrane ATP- coupled proton transport |
|
Nucleotide/ nucleoside biosynthesis |
||||||
66 | 489510278 | CLP_1207 | Pseudouridine synthase, RluA family | 0.86 | Nucleoside synthesis | |
67 | 488642701 | CLP_3018 | Nucleoside diphosphate kinase (NDK) | 2.09 | Nucleotide biosynthesis | |
68 | 488644020 | CLP_1400 | Uridine kinase (UDK) | 1.27 | Pyrimidine biosynthesis | |
69 | 488646320 | CLP_4393 | Oxidoreductase FAD/NAD | 1.46 | Fe-S (oxidoreductase) |
Pyrimidine biosynthesis |
70 | 489502503 | CLP_2848 | Dihydroorotate dehydrogenase B [NAD(+)], PyrK |
0.84 | Fe-S (electron transfer) |
Pyrimidine biosynthesis |
71 | 488642810 | CLP_2846 | Orotate phosphoribosyltransferase, PyrE |
0.26 | Pyrimidine biosynthesis | |
Translation | ||||||
72 | 489504979 | CLP_2730 | GTP-binding protein TypA/BipA | 2.16 | Translation | |
73 | 489502964 | CLP_2156 | Helicase domain protein | 3.82 | Translation | |
74 | 488645666 | CLP_3735 | Peptide chain release factor 1 | 1.05 | Translation | |
75 | 489506025 | CLP_3829 | Asparaginyl/glutamyl-tRNA amidotransferase GatC |
0.92 | Translation | |
76 | 489503907 | CLP_3482 | Flagellar assembly factor FliW | 1.25 | Translation | |
Other | ||||||
77 | 489503965 | CLP_3434 | Flagellar basal body protein | * | Bacterial-type flagellum motility |
|
78 | 489505096 | CLP_2731 | RNase J | 1.10 | rRNA processing | |
79 | 488642929 | CLP_2579 | GTPase Der | 1.98 | Ribosome biogenesis | |
80 | 489509514 | CLP_1938 | Chemotaxis response regulator | 1.04 | Stimulus response | |
81 | 488644530 | CLP_0974 | UspA domain protein | 1.89 | Stress response | |
82 | 489502173 | CLP_3317 | DegT/DnrJ/EryC1/StrS aminotransferase |
0.85 | Transferase aminotransferase |
|
83 | 489510263 | CLP_2488 | Protein RecA | 0.79 | DNA repair | |
84 | 489505855 | CLP_3987 | Ribonucleoside-diphosphate reductase |
1.54 | Oxidoreductase | DNA replication |
Downexpressed | ||||||
Biological process not assigned |
||||||
1 | 488644185 | CLP_1269 | Uncharacterized protein | −0.64 | Biol GO not assigned | |
2 | 489503664 | CLP_3067 | Uncharacterized protein | −3.20 | Biol GO not assigned | |
3 | 489504941 | CLP_2749 | p-47 protein | −2.11 | Biol GO not assigned | |
4 | 489505689 | CLP_1082 | Uncharacterized protein | * | Biol GO not assigned | |
5 | 489501399 | CLP_1582 | TPR repeat protein | * | Biol GO not assigned | |
6 | 489507297 | CLP_4257 | Uncharacterized protein | * | Biol GO not assigned | |
7 | 489510276 | CLP_2354 | Uncharacterized protein | −1.42 | Biol GO not assigned | |
Carbohydrate metabolism |
||||||
8 | 489509381 | CLP_1388 | Propionate CoA-transferase | −2.21 | Likely uses butyryl- CoA as the substrate |
Carbohydrate metabolism |
9 | 489502979 | CLP_0779 | Transaldolase | −1.55 | Carbohydrate metabolism | |
10 | 488644944 | CLP_0793 | Pyruvate formate-lyase-activating enzyme |
−1.85 | Fe-S | Carbohydrate metabolism |
11 | 489505871 | CLP_3853 | Butyryl-CoA dehydrogenase | −0.95 | Carbohydrate metabolism: butyrate synthesis pathway |
|
12 | 489506129 | CLP_3852 | Electron transfer flavoprotein, beta subunit |
−1.13 | Electron transfer | Carbohydrate metabolism: butyrate synthesis pathway |
13 | 906848776 | CLP_3850 | 3-Hydroxybutyryl-CoA dehydrogenase | −1.24 | Carbohydrate metabolism: butyrate synthesis pathway |
|
Translation | ||||||
14 | 488643005 | CLP_2502 | 30S ribosomal protein S15 | −0.78 | Translation | |
15 | 488645977 | CLP_4028 | 30S ribosomal protein S19 | −1.16 | Translation | |
16 | 488645980 | CLP_4025 | 50S ribosomal protein L16 | −0.72 | Translation | |
17 | 488645984 | CLP_4021 | 50S ribosomal protein L24 | * | Translation | |
18 | 488645990 | CLP_4015 | 30S ribosomal protein S5 | −0.77 | Translation | |
19 | 488645998 | CLP_4006 | 30S ribosomal protein S13 | −1.66 | Translation | |
20 | 488646007 | CLP_3997 | 50S ribosomal protein L13 | −0.87 | Translation | |
21 | 488646008 | CLP_3996 | 30S ribosomal protein S9 | −0.77 | Translation | |
22 | 488646514 | CLP_4041 | 50S ribosomal protein L10 | −0.84 | Translation | |
23 | 489502574 | CLP_2872 | 50S ribosomal protein L25 | −1.72 | Translation | |
24 | 489503008 | CLP_2520 | Ribosome-recycling factor | * | Translation | |
25 | 488646138 | CLP_3844 | 60-kDa chaperonin | −0.94 | Protein refolding | Translation |
rRNA processing | ||||||
26 | 488642944 | CLP_2563 | Probable dual-specificity RNA methyltransferase RlmN |
* | Fe-S | rRNA processing |
27 | 489508929 | CLP_3179 | rRNA small-subunit methyltransferase | * | rRNA processing | |
Nucleotide/ nucleoside biosynthesis |
||||||
28 | 489507369 | CLP_4280 | Ribose-phosphate pyrophosphokinase | * | Nucleotide biosynthesis | |
29 | 488642862 | CLP_2788 | 5-(Carboxyamino)imidazole ribonucleotide mutase, PurE |
* | Nucleotide biosynthesis | |
Other | ||||||
30 | 488642931 | CLP_2577 | Stage IV sporulation protein A | −3.09 | Sporulation | |
31 | 653633918 | AWN73_ 11055 |
Serine protease | −2.83 | Protein kinase | |
32 | 488643856 | CLP_1581 | Heat shock protein Hsp20 | −2.40 | Stress response | |
33 | 489507712 | CLP_3749 | Peptidoglycan-binding LysM | −2.19 | Peptidoglycan metabolism |
|
34 | 488643009 | CLP_2498 | Aspartokinase | * | Amino acid biosynthesis | |
35 | 489504328 | CLP_3792 |
N-Acetylgalactosamine permease IID component |
* | PTS | Sugar transport |
FC is reported as log2 AE/AN ratio, as described in Materials and Methods. * indicates proteins for which FC has not been calculated because they have been detected only in aerobic or anaerobic conditions.
Notes column reports some specific relevant functional protein features discussed in the text.
With respect to carbohydrate metabolism, some proteins related to polysaccharide catabolic processes were upregulated in the AE environment, whereas three enzymes responsible for converting acetoacetyl-CoA to butyryl-CoA (3-hydroxybutyryl-CoA dehydrogenase, acyl-CoA dehydrogenase, and electron transfer flavoprotein subunit beta) were downregulated in the AE environment. Of note, the pyruvate formate lyase (PFL)-activating protein was also decreased in the AE environment.
Effects of air exposure on extracellular metabolism evaluated by 1H NMR spectroscopy.
Nuclear magnetic resonance (NMR) spectroscopy was used to identify and quantify fermentation products in the extracellular medium for both strains after a 5-h incubation under either AN or AE conditions (Fig. 6).
The formate levels were significantly lower (P = 0.004) in the AE extracellular medium than in the AN extracellular medium, whereas the acetate content was significantly higher in the AE medium than in the AN medium (P = 0.003). Moreover, there was a significant increase in the acetate/butyrate ratio (P = 0.004) in the media of both strains under AE conditions compared to the strains grown under AN conditions. There were no other significant differences in the levels of metabolites linked to pyruvate metabolism (lactate, ethanol, and alanine).
DISCUSSION
Anaerobically cultured C. butyricum type E strains continued to grow and produce BoNT/E in liquid medium during the transition from anaerobic to aerated conditions, although aeration for 5 h resulted in a dissolved oxygen concentration in the final cultures of ∼5 ppm, which does not support aerobic life (27) but is not the oxygen-free conditions required for vegetative growth of anaerobic clostridia.
While the OD600 data indicated similar growth rates under AN and AE conditions over 5 h, viable cell counts were lower in the AE environment than in the AN environment at the end of the culture period, suggesting that bacterial growth was decreased under the stress conditions of aeration compared to the ideal conditions of anaerobiosis. The lack of complete correlation between OD and viable cell count data under stress conditions has been reported for other bacteria (28) and may be because OD values are affected by light scattering due to cell debris and stress-induced bacterial cell damage.
C. butyricum type E strains continued to grow upon air exposure only when the starting exponentially growing cultures contained at least 103 cells/ml. The absence of growth at lower initial bacterial densities could be a result of either oxygen toxicity or decreased cell-to-cell signaling (24). The absence of spores in the cultures of C. butyricum type E strains after a 5-h aeration indicates that sporulation did not occur in the evaluated period and that aerotolerance was not due to spore formation. Sporulation in clostridia has been reported to be strain dependent (29).
Of note, our results indicated that even BoNT/E production was maintained during the transition from AN to AE conditions. BoNT/E protein and toxicity levels were increased in the cultures transferred to AE conditions for 24 h, although the levels were significantly lower than those in cultures maintained under AN conditions for the same period. The significantly lower BoNT/E protein and toxicity levels detected in the AE environment than those in the AN environment can be attributed to the decreased growth rates under the former conditions. Moreover, our proteomics analysis revealed that the abundance of several ribosomal proteins was lower under AE conditions, evidencing that the overall protein synthesis could be downregulated in the presence of oxygen, which is a general adaptive response to acute stress in bacteria (30). Additional effects due to downregulation of BoNT/E synthesis under AE conditions cannot be excluded. Little is known on the toxin synthesis regulation in BoNT/E-producing clostridial strains. We recently hypothesized that production of BoNT/E in C. butyricum type E strains might be controlled at the posttranscriptional and/or posttranslational levels (i.e., protein folding, secretion, and degradation) (31); accordingly, since oxygen is known to modify the structure and function of proteins, BoNT/E inactivation by oxidative damage could be expected (32). Recently, it was shown that BoNT/E expression in C. botulinum type E strains is positively regulated by the sporulation regulator Spo0A (33); our proteomics results showed similar Spo0A protein levels in the C. butyricum type E broth cultures incubated for 5 h under AN and under AE conditions (see Table S1 in the supplemental material). The absence of significant differences in the BoNT/E protein levels under AN and AE conditions in the proteomics analysis may be due to only cellular proteins being analyzed whereas BoNT/E protein is an exotoxin secreted by clostridia in the medium (34). Nevertheless, cellular levels of the protein P-47 were decreased under AE conditions (Table 1); this protein is encoded in the bont/e toxin gene cluster and coexpressed with BoNT/E, although the two proteins might not be secreted together (35).
Our proteomics analyses indicated that membrane transport was one of the most affected processes under AE conditions: many proteins overexpressed in AE contain or interact with ATP-binding cassettes (ABC transporters) and are involved in transporting solutes across membranes. Other overexpressed proteins are involved in sugar transport, especially five proteins (Table 1) from the phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS), which is a major mechanism used by bacteria for carbohydrate uptake and conversion into phosphoesters during transport (36). Moreover, the proteomic analysis indicated that acetylmuramoyl-l-alanine amidase and cell wall hydrolase, which are involved in peptidoglycan catabolism, were upregulated under AE conditions.
Other proteins involved in protein transport, including SecD and SecF, which are members of the Sec protein translocase complex, were overexpressed in the AE environment. These results indicate that molecular trafficking through the cellular membrane and carbohydrate metabolism are enhanced under AE conditions, suggesting that energy requirements are higher.
Aeration also induced the expression of proteins involved in redox homeostasis, including NADH oxidase, rubrerythrin, peroxiredoxin, and thioredoxin reductase. In this respect, Kawasaki et al. (4) detected the activity of NAD(P)H peroxidase and superoxide dismutase (SOD) in nonneurotoxigenic C. butyricum strains exposed to air. It is known that rubrerythrin has a strong NAD(P)H peroxidase activity (10). Moreover, enzymes homologous to peroxiredoxin and thioredoxin reductase prevent the inactivation of manganese-SOD (Mn-SOD) of Saccharomyces cerevisiae under oxidative stress, contributing to the antioxidant defense in yeast (37). Since an Mn-SOD gene is carried in the genome of three closely related neurotoxigenic C. butyricum type E strains, we speculate that peroxiredoxin and thioredoxin reductase in these strains may protect Mn-SOD.
The proteomic analysis indicated that proteins involved in sulfur metabolism were upregulated under AE conditions, including two subunits of the bifunctional enzyme CysN/CysC sulfate adenylyltransferase and sulfite reductase: these enzymes are involved in cysteine production, and this sulfur-containing amino acid strongly inhibits toxin production in C. difficile (38). Furthermore, several cysteine-containing proteins, often required for protein folding or involved in cellular response to oxidative stress, and (Fe-S) cluster-containing proteins are sensitive to oxidization, and many of these proteins were overexpressed under AE conditions (Table 1), suggesting the need to restore the pool of these proteins in their active state. In contrast, the PFL-activating enzyme, an oxygen-sensitive Fe-S binding protein, responsible for the conversion of pyruvate into acetyl-CoA and formate in anaerobic metabolism (Fig. 7), was downregulated under AE conditions. In accordance, the formate content was significantly lower in the supernatants from aerated C. butyricum type E cells than in those from anaerobic cells. Formate is ultimately converted to carbon dioxide and hydrogen in the metabolic pathways of clostridial species (Fig. 7). Therefore, the lower levels of formate resulting from the decreased expression of the PFL-activating enzyme, together with the upregulation of hydrogen-consuming enzymes, may partially explain the decreased formation of gas in the cultures upon aeration.
Furthermore, the proteomics analysis showed that three enzymes of the butyrate metabolic pathway were downregulated under AE conditions, suggesting that oxygen induced a decrease in butyrate biosynthesis. In line with this result, butyrate content was decreased, although not significantly, in the aerated supernatants compared to nonaerated supernatants; concomitantly, the acetate levels were significantly higher in the aerated supernatants, suggesting that oxygen caused a shift in electron flow toward acetate formation instead of butyrate formation in these C. butyricum type E strains. The acetate/butyrate ratio in nonneurotoxigenic C. butyricum strains is increased as the hydrogen partial pressure is decreased in the medium (39). Moreover, the higher levels of several proteins putatively involved in DNA replication and repair and nucleotide biosynthesis and flagellum-related proteins under AE conditions suggest that the DNA damage response may be activated and proton-driven bacterial motility enhanced. The improved bacterial motility may increase proton consumption and consequently decrease the generation of ROS (40). Furthermore, our finding that a protein involved in an early stage of sporulation was down-expressed in the AE environment is consistent with the absence of spores in C. butyricum type E cultures after a 5-h exposure to ambient air.
In conclusion, the enhanced aerotolerance of neurotoxigenic C. butyricum type E strains that we report here may have public health significance. First, it may increase the opportunities for these microorganisms to colonize the newborn intestine, because the intestine at birth is aerobic and gradually becomes anaerobic (18); in addition, the ability to inactivate the ROS generated by inflammatory processes in the gut may be advantageous to intestine-colonizing neurotoxigenic C. butyricum type E strains. To date, most neurotoxigenic C. butyricum type E strains have been involved in infant intestinal toxemia botulism (21–23, 41, 42). It is of interest that Cassir et al. (43) recently found a significant association between oxidized gut environment and the presence of cytotoxic (nonneurotoxigenic) C. butyricum strains in preterm neonates with necrotizing enterocolitis. Furthermore, the studies on aerotolerance may improve the isolation and identification of BoNT-producing clostridia, considering that other clostridial strains have been misidentified because of their aerotolerance features (11).
To our knowledge, this study is the first to demonstrate vegetative growth and toxin production upon air exposure for BoNT-producing clostridial strains. The results point to the need for further research on the aerotolerance of other BoNT-producing clostridial strains, especially C. botulinum strains, which are more frequently involved in botulism.
MATERIALS AND METHODS
Bacterial strains and growth conditions.
Two neurotoxigenic C. butyricum type E strains (ISS-21 and ISS-190) isolated from distinct infant botulism cases in Italy were used in this study (41, 42). The effect of atmospheric oxygen on the vegetative growth of these strains was analyzed by using a culture approach similar to that used by other authors for similar purposes (6, 14, 15), with modifications. Tryptone-peptone-glucose-yeast extract (TPGY) broth (pH 7.0) (Oxoid) without the addition of reducing agents was used to grow the strains. Clostridial growth was monitored by measuring the optical densities of the cell suspensions at 600 nm (OD600) at regular time intervals (Biophotometer; Eppendorf). The strains were grown to the mid-exponential phase (OD600 of ∼1) at 37°C in a jar with an anaerobic gas generator (Anaerogen; Oxoid) (starting cultures). Then, 50% of the exponentially growing cultures were transferred to flasks (flask-to-medium ratio, 1:10) and incubated in ambient air (aerated or AE conditions) in an incubator shaker (New Brunswick Scientific; model G25) at 200 rpm and 37°C for 5 h; the remaining volumes of the starting cultures were overlaid with sterile Vaseline oil to produce oxygen-depleted (anaerobic or AN) conditions and were incubated at 37°C for 5 h. The experimental time of 5 h was empirically chosen in order to assay the differences between the vegetative cultures under the AN and AE conditions before sporulation occurred. Growth curves were generated using the OD600 values. These experiments were repeated three times.
The AE cultures were streaked on nonselective tryptone soy agar (TSA) plates, and the plates were incubated at 37°C for 24 h to detect contamination with aerobic bacteria at the end of culturing. To assess the presence of spores, slides from the AE cultures were examined microscopically; in addition, aliquots of the AE cultures grown for 5 h were treated at 70°C for 10 min and streaked on egg yolk agar plates, and bacterial growth was assessed after a 48-h incubation at 37°C under anaerobiosis. The pH values of the cultures were determined using a pH meter (Mettler Toledo). The dissolved oxygen levels were measured using a dissolved oxygen meter (model HI9146; Hanna Instruments). Viable bacteria were counted using the three-tube most probable number (MPN) method as previously described (31). The average number of viable cells was measured by combining the data from three separate experiments.
Student’s t test was used to perform all pairwise comparisons between OD600 values or viable cell counts under AN and AE conditions. All calculations were performed using GraphPad Prism software version 6 (GraphPad Software, San Diego, CA), and P values < 0.05 were considered statistically significant.
Quantification of BoNT/E protein and toxicity levels.
BoNT/E protein and toxicity levels were measured in the starting (mid-exponential-growth-phase) cultures and in cultures grown under AN or AE conditions for 24 h. The cultures were centrifuged at 12,000 × g for 20 min at 4°C.
BoNT/E protein levels in the supernatants from two assays were quantified in duplicate using a commercial BoNT/E enzyme-linked immunosorbent assay (ELISA) kit (Tetracore). Absorbance was measured at 405 nm using a Multiskan Go microplate spectrophotometer (Thermo Scientific). The BoNT/E concentrations (ng/ml) were determined using the standard toxin concentration curve provided by the manufacturer, and the mean and standard deviation were calculated. Student’s t test was used to perform pairwise comparisons, with statistical significance at P < 0.05.
A mouse bioassay was used for determining BoNT/E toxicity. The culture supernatants were treated with 0.5% trypsin at 1:250 for 20 min at room temperature, 2-fold diluted in phosphate buffer (pH 6.4) containing 0.2% gelatin, and injected intraperitoneally into groups of two male CD1 mice (weight of 25 g). The mice were monitored over 4 days for signs of botulism (44), the number of deaths was recorded, and the results were expressed as mouse lethal dose (MLD) per ml. The mouse bioassay was done twice.
The experimental animal protocol adhered to Directive 2010/63/EU on the protection of animals used for scientific purposes of the European Parliament and was approved by the Italian Ministry of Health (authorization no. 291/2015).
Harvesting and lysis of bacterial cells.
Fifty milliliters of the AE and AN cultures grown for 5 h was centrifuged at 5,000 × g for 15 min. Each culture supernatant (2 ml) was mixed with 18 ml of 80% ethanol and stored at −80°C until analysis of metabolites. For cell protein extraction, the pellets were washed twice with 50 mM phosphate buffer (pH 7.8) containing 0.1 mM EDTA and suspended in 500 μl of a solution containing 25 mM Tris, pH 7.4, 0.1 mM EDTA, 0.2% Triton X-100, 0.2 mg/ml lysozyme, 0.1 mg/ml RNase, 0.1 mg/ml DNase, and 1× protease inhibitor cocktail (Sigma-Aldrich). After 30 min at 37°C, the suspensions were subjected to ultrasound treatment (10 cycles of 45 s on and 2 min off at a frequency of 20 kHz) (Sonics VCX 500) on ice. Samples were centrifuged at 25,000 × g for 10 min at 4°C, and the protein concentration in the supernatants was estimated using the Bio-Rad protein assay kit with bovine serum albumin used as a standard. The supernatants were stored at −80°C until proteomic analyses.
Proteomic analysis.
Proteins were separated on a 1-D gel, 4 to 12%, and colored by Coomassie blue staining. Each gel lane was cut in 12 to 15 contiguous slices, treated with DTT and iodoacetamide, and digested with trypsin (Promega Corporation), as described by Shevchenko et al. (45). The peptide mixtures were analyzed by nanoflow reversed-phase liquid chromatography–tandem mass spectrometry (nLC-MS/MS) using an Ultimate 3000 HPLC (Dionex) coupled online with a linear ion trap (LTQ; Thermo). Peptides were desalted in a trap column and separated in a 10-cm silica capillary as previously described (46). Tandem mass spectra were acquired in data-dependent mode (top five) and searched against Clostridium proteins (C. butyricum type E strain BL5262 taxonomy identity 632245) from the NCBI database using Proteome Discoverer version 1.4 (Thermo Electron) filtering spectral matches with a Percolator node with a q-value based false-discovery rate (FDR) of 0.01. Specific trypsin cleavages were admitted, with two possible missed cleavages. Only proteins identified with at least two peptides were considered, and only proteins detected in at least three replicates were considered for further analysis. The analyses were performed in quintuplicates. A label-free quantitative analysis was performed to identify DEPs in proteomic analyses, comparing AE and AN conditions. Only proteins identified in at least three replicates were selected for identification of DEPs. The proteins expressed under one condition were excluded from the statistical analysis but used for the successive analysis step. Protein abundances were estimated using normalized spectral abundance factor (NSAF) values calculated normalizing the spectral counts against the protein length and the sum of spectral counts in the corresponding run. Identification of DEPs was performed using the method proposed by Pavelka et al. (47), effectively applied in spectral-count-based proteome quantification (48), showing a good sensitivity-specificity tradeoff. The method consists of signal-to-noise-ratio (STN) statistics improved using protein-specific estimates of standard deviation (SD) derived by the power-law global error model (PLGEM), which well describes the SD-versus-mean dependence in NSAF data sets. A resampling-based algorithm is then used for multiple testing adjustment to control the false-positive rate (FPR). The PLGEM-STN method was applied using the ‘plgem’ Bioconductor (49) package in step-by-step mode. Further details on the method are reported in the work of Pavelka et al. (47). Our NSAF data set showed a good fitting to the PLGEM (adjusted r2 = 0.996); PLGEM-STN was thus used to compare NSAF values under AE and AN conditions; multiple testing correction was applied, setting in ‘plgem’ a 1,000-iteration resampling and a ‘delta’ (parameter for FPR estimate) of 0.05. The fold change (FC) for each protein was estimated as the log2 of the average NSAF(AE)/average NSAF(AN) ratio. The proteins showing both adjusted P values of <0.05 and |FC| of >0.6 were predicted as differentially expressed in our data set. The proteins up- or downrepresented and those uniquely identified under AE or AN conditions were grouped by biological function as retrieved from the UniProt database and analyzed by the STRING tool, version 10.5 (http://www.string-db.org), with a minimum required interaction score of 0.7.
High-resolution NMR spectroscopy.
High-resolution NMR (Bruker Avance spectrometer; Karlsruhe, Germany) analyses were performed on extracellular medium at 25°C and 400 MHz. 1H magnetic resonance spectroscopy (MRS) spectra were acquired and analyzed as previously described (50). Metabolite quantification was expressed as the percentage of metabolite concentration versus all investigated metabolites. Differences in the metabolite concentration under AE and AN conditions were evaluated using the Wilcoxon signed-rank test at a significance level of P < 0.01.
Availability of data.
The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the data set identifier PXD013383.
ACKNOWLEDGMENTS
L.M. and P.P. received financial supports from Regione Lazio of Italy (FILAS-RU-2014-1020). The study was also supported by internal ISS research funding. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank Concetta Scalfaro, Claudia D’Agostino, and Carlo Giovannelli for technical assistance.
REFERENCES
- 1.Rainey FA, Hollen BJ, Small AGI. 2009. Clostridium Prazmowski 1880, 23, AL, p 738–828. In De Vos P, Garrity GM, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (ed), Bergey’s manual of systematic bacteriology, 2nd ed, vol 3 Springer, New York, NY. [Google Scholar]
- 2.Brioukhanov AL, Netrusov AI. 2007. Aerotolerance of strictly anaerobic microorganisms and factors of defense against oxidative stress: a review. Prikl Biokhim Mikrobiol 43:635–652. (In Russian.) [PubMed] [Google Scholar]
- 3.Imlay JA. 2008. How obligatory is anaerobiosis? Mol Microbiol 68:801–804. doi: 10.1111/j.1365-2958.2008.06213.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kawasaki S, Nakagawa T, Nishiyama Y, Benno Y, Uchimura T, Komagata K, Kozaki M, Niimura Y. 1998. Effect of oxygen on the growth of Clostridium butyricum (type species of the genus Clostridium), and the distribution of enzymes for oxygen and for active oxygen species in clostridia. J Ferment Bioeng 86:368–372. doi: 10.1016/S0922-338X(99)89006-0. [DOI] [Google Scholar]
- 5.Kawasaki S, Watamura Y, Ono M, Watanabe T, Takeda K, Niimura Y. 2005. Adaptive responses to oxygen stress in obligatory anaerobes Clostridium acetobutylicum and Clostridium aminovalericum. Appl Environ Microbiol 71:8442–8450. doi: 10.1128/AEM.71.12.8442-8450.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hillmann F, Fischer RJ, Saint-Prix F, Girbal L, Bahl H. 2008. PerR acts as a switch for oxygen tolerance in the strict anaerobe Clostridium acetobutylicum. Mol Microbiol 68:848–860. doi: 10.1111/j.1365-2958.2008.06192.x. [DOI] [PubMed] [Google Scholar]
- 7.Kawasaki S, Ishikura J, Chiba D, Nishino T, Niimura Y. 2004. Purification and characterization of an H2O-forming NADH oxidase from Clostridium aminovalericum: existence of an oxygen-detoxifying enzyme in an obligate anaerobic bacteria. Arch Microbiol 181:324–330. doi: 10.1007/s00203-004-0659-3. [DOI] [PubMed] [Google Scholar]
- 8.Leja KB, Myszka K, Olkowicz M, Juzwa W, Czaczyk K. 2014. Clostridium bifermentans as an aero-tolerant exponent of strictly anaerobe genera. Adv Microbiol 4:216–224. doi: 10.4236/aim.2014.44028. [DOI] [Google Scholar]
- 9.Shabuer G, Ishida K, Pidot SJ, Roth M, Dahse HM, Hertweck C. 2015. Plant pathogenic anaerobic bacteria use aromatic polyketides to access aerobic territory. Science 350:670–674. doi: 10.1126/science.aac9990. [DOI] [PubMed] [Google Scholar]
- 10.Whitham JM, Tirado-Acevedo O, Chinn MS, Pawlak JJ, Grunden AM. 2015. Metabolic response of Clostridium ljungdahlii to oxygen exposure. Appl Environ Microbiol 81:8379–8391. doi: 10.1128/AEM.02491-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fujitani S, Liu CX, Finegold SM, Song YL, Mathisen GE. 2007. Clostridium tertium isolated from gas gangrene wound misidentified as Lactobacillus spp initially due to aerotolerant feature. Anaerobe 13:161–165. doi: 10.1016/j.anaerobe.2007.03.002. [DOI] [PubMed] [Google Scholar]
- 12.Küsel K, Karnholz A, Trinkwalter T, Devereux R, Acker G, Drake HL. 2001. Physiological ecology of Clostridium glycolicum RD-1, an aerotolerant acetogen isolated from sea grass roots. Appl Environ Microbiol 67:4734–4741. doi: 10.1128/AEM.67.10.4734-4741.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Edwards AN, Karim ST, Pascual RA, Jowhar LM, Anderson SE, McBride SM. 2016. Chemical and stress resistances of Clostridium difficile spores and vegetative cells. Front Microbiol 7:1698. doi: 10.3389/fmicb.2016.01698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Trinh S, Briolat V, Reysset G. 2000. Growth response of Clostridium perfringens to oxidative stress. Anaerobe 6:233–240. doi: 10.1006/anae.2000.0346. [DOI] [Google Scholar]
- 15.Briolat V, Reysset G. 2002. Identification of the Clostridium perfringens genes involved in the adaptive response to oxidative stress. J Bacteriol 184:2333–2343. doi: 10.1128/JB.184.9.2333-2343.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hillmann F, Döring C, Riebe O, Ehrenreich A, Fischer RJ, Bahl H. 2009. The role of PerR in O2-affected gene expression of Clostridium acetobutylicum. J Bacteriol 191:6082–6093. doi: 10.1128/JB.00351-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hatheway CL. 1992. Clostridium botulinum and other clostridia that produce botulinum neurotoxin, p 3–20. In Hauschild AHW, Dodds KL (ed), Clostridium botulinum. Marcel Dekker, New York, NY. [Google Scholar]
- 18.Houghteling PD, Walker WA. 2015. Why is initial bacterial colonization of the intestine important to infants’ and children’s health? J Pediatr Gastroenterol Nutr 60:294–307. doi: 10.1097/MPG.0000000000000597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Anniballi F, Auricchio B, Fiore A, Lonati D, Locatelli CA, Lista F, Fillo S, Mandarino G, De Medici D. 2017. Botulism in Italy, 1986 to 2015. Euro Surveill 22:30550. doi: 10.2807/1560-7917.ES.2017.22.24.30550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Meng X, Yamakawa K, Zou K, Wang X, Kuang X, Lu C, Wang C, Yamakawa K, Nakamura S. 1997. Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism. J Clin Microbiol 35:2160–2162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Abe Y, Negasawa T, Monma C, Oka A. 2008. Infantile botulism caused by Clostridium butyricum type E toxin. Pediatr Neurol 38:55–57. doi: 10.1016/j.pediatrneurol.2007.08.013. [DOI] [PubMed] [Google Scholar]
- 22.Dykes JK, Lúquez C, Raphael BH, McCroskey LM, Maslanka SE. 2015. Laboratory investigation of the first case of Clostridium butyricum type E infant botulism in the United States. J Clin Microbiol 53:3363–3365. doi: 10.1128/JCM.01351-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Shelley EB, O’Rourke D, Grant K, McArdle E, Capra L, Clarke A, McNamara E, Cunney R, McKeown P, Amar CF, Cosgrove C, Fitzgerald M, Harrington P, Garvey P, Grainger F, Griffin J, Lynch BJ, McGrane G, Murphy J, Ni Shuibhne N, Prosser J. 2015. Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins. Epidemiol Infect 143:461–469. doi: 10.1017/S0950268814002672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Miller MB, Bassler BL. 2001. Quorum sensing in bacteria. Annu Rev Microbiol 55:165–199. doi: 10.1146/annurev.micro.55.1.165. [DOI] [PubMed] [Google Scholar]
- 25.Couesnon A, Raffestin S, Popoff MR. 2006. Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR. Microbiology 152:759–770. doi: 10.1099/mic.0.28561-0. [DOI] [PubMed] [Google Scholar]
- 26.Iacobino A, Scalfaro C, Franciosa G. 2013. Structure and genetic content of the megaplasmids of neurotoxigenic Clostridium butyricum type E strains from Italy. PLoS One 8:e71324. doi: 10.1371/journal.pone.0071324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Somerville GA, Proctor RA. 2013. Cultivation conditions and the diffusion of oxygen into culture media: the rationale for the flask-to-medium ratio in microbiology. BMC Microbiol 13:9. doi: 10.1186/1471-2180-13-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Francois K, Devlieghere F, Standaert AR, Geeraerd AH, Cools I, Van Impe JF, Debevere J. 2005. Environmental factors influencing the relationship between optical density and cell count for Listeria monocytogenes. J Appl Microbiol 99:1503–1515. doi: 10.1111/j.1365-2672.2005.02727.x. [DOI] [PubMed] [Google Scholar]
- 29.Dürre P. 2014. Physiology and sporulation in Clostridium. Microbiol Spectr 2:TBS-0010-2012. doi: 10.1128/microbiolspec.TBS-0010-2012. [DOI] [PubMed] [Google Scholar]
- 30.Guerra-Moreno A, Isasa M, Bhanu MK, Waterman DP, Eapen VV, Gygi SP, Hanna J. 2015. Proteomic analysis identifies ribosome reduction as an effective proteotoxic stress response. J Biol Chem 290:29695–29706. doi: 10.1074/jbc.M115.684969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Scalfaro C, Iacobino A, Grande L, Morabito S, Franciosa G. 2016. Effects of megaplasmid loss on growth of neurotoxigenic Clostridium butyricum strains and botulinum neurotoxin type E expression. Front Microbiol 7:217. doi: 10.3389/fmicb.2016.00217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Cabiscol E, Tamarit J, Ros J. 2000. Oxidative stress in bacteria and protein damage by reactive oxygen species. Int Microbiol 3:3–8. [PubMed] [Google Scholar]
- 33.Mascher G, Mertaoja A, Korkeala H, Lindström M. 2017. Neurotoxin synthesis is positively regulated by the sporulation transcription factor Spo0A in Clostridium botulinum type E. Environ Microbiol 19:4287–4300. doi: 10.1111/1462-2920.13892. [DOI] [PubMed] [Google Scholar]
- 34.Pirazzini M, Rossetto O, Eleopra R, Montecucco C. 2017. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69:200–235. doi: 10.1124/pr.116.012658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lam KH, Qi R, Liu S, Kroh A, Yao G, Perry K, Rummel A, Jin R. 2018. The hypothetical protein P47 of Clostridium botulinum E1 strain Beluga has a structural topology similar to bactericidal/permeability-increasing protein. Toxicon 147:19–26. doi: 10.1016/j.toxicon.2017.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. 2016. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44:D457–D462. doi: 10.1093/nar/gkv1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Pedrajas JR, Carreras A, Valderrama R, Barroso JB. 2010. Mitochondrial 1-Cys-peroxiredoxin/thioredoxin system protects manganese-containing superoxide dismutase (Mn-SOD) against inactivation by peroxynitrite in Saccharomyces cerevisiae. Nitric Oxide 23:206–213. doi: 10.1016/j.niox.2010.06.004. [DOI] [PubMed] [Google Scholar]
- 38.Dubois T, Dancer-Thibonnier M, Monot M, Hamiot A, Bouillaut L, Soutourina O, Martin-Verstraete I, Dupuy B. 2016. Control of Clostridium difficile physiopathology in response to cysteine availability. Infect Immun 84:2389–2405. doi: 10.1128/IAI.00121-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Zhang C, Yang H, Yang F, Ma Y. 2009. Current progress on butyric acid production by fermentation. Curr Microbiol 59:656–663. doi: 10.1007/s00284-009-9491-y. [DOI] [PubMed] [Google Scholar]
- 40.Kim J-C, Oh E, Kim J, Jeon B. 2015. Regulation of oxidative stress resistance in Campylobacter jejuni, a microaerophilic foodborne pathogen. Front Microbiol 6:751. doi: 10.3389/fmicb.2015.00751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Aureli P, Fenicia L, Pasolini B, Gianfranceschi M, McCroskey LM, Hatheway C. 1986. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 154:207–211. doi: 10.1093/infdis/154.2.207. [DOI] [PubMed] [Google Scholar]
- 42.Fenicia L, Da Dalt L, Anniballi F, Franciosa G, Zanconato S, Aureli P. 2002. A case of infant botulism due to Clostridium butyricum type E associated with Clostridium difficile colitis. Eur J Clin Microbiol Infect Dis 21:736–738. [DOI] [PubMed] [Google Scholar]
- 43.Cassir N, Benamar S, Khalil JB, Croce O, Saint-Faust M, Jacquot A, Million M, Azza S, Armstrong N, Henry M, Jardot P, Robert C, Gire C, Lagier JC, Chabrière E, Ghigo E, Marchandin H, Sartor C, Boutte P, Cambonie G, Simeoni U, Raoult D, La Scola B. 2015. Clostridium butyricum strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates. Clin Infect Dis 61:1107–1115. doi: 10.1093/cid/civ468. [DOI] [PubMed] [Google Scholar]
- 44.Centers for Disease Control and Prevention. 1998. Botulism in the United States, 1899–1996, handbook for epidemiologists, clinicians and laboratory workers. Centers for Disease Control and Prevention, Atlanta, GA. [Google Scholar]
- 45.Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 5:850–858. doi: 10.1021/ac950914h. [DOI] [PubMed] [Google Scholar]
- 46.Cucco F, Palumbo E, Camerini S, D’Alessio B, Quarantotti V, Casella ML, Rizzo IM, Cukrov D, Delia D, Russo A, Crescenzi M, Musio A. 2018. Separase prevents genomic instability by controlling replication fork speed. Nucleic Acids Res 46:267–278. doi: 10.1093/nar/gkx1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pavelka N, Pelizzola M, Vizzardelli C, Capozzoli M, Splendiani A, Granucci F, Ricciardi-Castagnoli P. 2004. A power law global error model for the identification of differentially expressed genes in microarray data. BMC Bioinformatics 5:203. doi: 10.1186/1471-2105-5-203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Pavelka N, Fournier ML, Swanson SK, Pelizzola M, Ricciardi-Castagnoli P, Florens L, Washburn MP. 2008. Statistical similarities between transcriptomics and quantitative shotgun proteomics data. Mol Cell Proteomics 7:631–644. doi: 10.1074/mcp.M700240-MCP200. [DOI] [PubMed] [Google Scholar]
- 49.Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. doi: 10.1186/gb-2004-5-10-r80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Iorio E, Ricci A, Bagnoli M, Pisanu ME, Castellano G, Di Vito M, Venturini E, Glunde K, Bhujwalla ZM, Mezzanzanica D, Canevari S, Podo F. 2010. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res 70:2126–2135. doi: 10.1158/0008-5472.CAN-09-3833. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.